Pharma Mar earns 35 million euros until June

The pharmaceutical company PharmaMar registered a drop of 16.

Thomas Osborne
Thomas Osborne
01 August 2022 Monday 06:53
13 Reads
Pharma Mar earns 35 million euros until June

The pharmaceutical company PharmaMar registered a drop of 16.78% on the stock market last week, the worst evolution recorded on the Ibex 35. The firm presented its results up to June, in which it reduced the net result from 43.2 million euros to 34 .9 million, with a fall of 8 million equivalent to 19%.

Between January and June, the company obtained a total turnover of 101.43 million euros, which translates into a progression of 3% when compared to the 98.6 million euros that it entered at the end of the first half of 2021.

As of June 30 of the current year, it had 35.2 million euros in cash from operating activities, while its cash position reached 251.5 million euros, 18.2% higher. The financial debt fell by 10% in the first half, to 41 million euros, which is the lowest figure in 20 years.